Table 3 Risk ratio (95% CI) of specific adverse effects between different treatment groups
Comparison | GI AE | CV AE | CNS AE | MU AE | Infection | Skin AE | Others |
|---|---|---|---|---|---|---|---|
G vs PBO | 0.99(0.79, 1.23) | NA | 0.72(0.46, 1.10) | 1.52(0.88, 2.63) | 1.07(0.50, 2.32) | 0.80(0.38, 1.68) | 1.21(0.98, 1.48) |
C vs PBO | 0.35(0.14, 0.87) | 1.13(0.45, 2.84) | 0.79(0.37, 1.67) | NA | 0.98(0.72, 1.34) | 1.00(0.41, 2.45) | NA |
G + C vs PBO | 2.79(0.30, 26.00) | NA | 1.86(0.36, 9.74) | 2.79(0.30, 26.00) | 2.79(0.12, 67.10) | NA | 4.66(0.23, 94.79) |
Overall | 0.92(0.74, 1.13) | 1.13(0.45, 2.84) | 0.77(0.54, 1.11) | 1.58(0.93, 2.70) | 1.01(0.76, 1.35) | 0.88(0.50, 1.55) | 1.22(1.00, 1.50) |